Health and Healthcare

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

577 Articles

Douglas A. McIntyre | Dec 18, 2009 at 7:15 AM EST

Friday’s Top Options Alert: Bristol-Myers & Mead Johnson (BMY, MJN)

Bristol-Myers Squibb Co. (NYSE: BMY) has been a real pest in the world of analyzing options trading activity. There has…

Douglas A. McIntyre | Dec 13, 2009 at 9:47 AM EST

The Unusual Suspects (ADBE, BBY, NKE, ORCL, RIMM, AMZN, AXA, BMY, MJN, OSIP, UUP, V, WFC)

The second half of December is supposed to be when trading volume starts slowing down. That does not look to be the case…

Douglas A. McIntyre | Nov 17, 2009 at 11:37 AM EST

FDA: Thin Blood, Sour Stomach (AZN)(BMY)(SNY)

The FDA is routinely criticized for being a poor steward of drug research and pharmaceutical side effects. The agency proved once…

Douglas A. McIntyre | Nov 16, 2009 at 9:29 AM EST

Bristol-Myers Cleans Up on Mead Johnson (BMY, MJN)

Bristol-Myers Squibb Company (NYSE: BMY) is going to completely separate itself from its holdings in Mead Johnson Nutrition Company (NYSE:…

Douglas A. McIntyre | Nov 16, 2009 at 4:00 AM EST

Media Digest 11/16/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

Reuters: The Ohio Attorney General is suing a number of Wall St. firms. Reuters: GM will start to repay part…

Douglas A. McIntyre | Oct 20, 2009 at 5:06 PM EDT

The 100 Hardest Working Brands In The World

There are a number of ways to rank brand values. One of the most important is the level at which…

Douglas A. McIntyre | Oct 12, 2009 at 7:18 AM EDT

Top Analyst Upgrades (AMD, AMGN, BDK, BMY, CTXS, KR, MA, PCG, SYMC, V, VMW)

These are the top early-bird analyst upgrades and positive research calls which we have seen from Wall Street early this…

Douglas A. McIntyre | Oct 9, 2009 at 7:43 AM EDT

Top Analyst Upgrades (AKS, BMY, CREE, JPM, LRCX, MAR, RIMM, SVNT, SE, VIA)

These are this Friday morning’s top Wall Street analyst upgrades and positive research calls: AK Steel (AKS) Raised to Buy…

Douglas A. McIntyre | Aug 31, 2009 at 4:03 AM EDT

Media Digest 8/31/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

Reuters: The best investment for Chinese companies may be the nation’s own 1.3 billion person home market. Reuters: Japan’s Democrats…

Douglas A. McIntyre | Aug 28, 2009 at 8:03 AM EDT

Top Analyst Upgrades and Downgrades (ABX, BDX, BMY, FUN, JCG, NEM, NENG, SNY, ZOLT)

These are this morning’s top pre-market analyst upgrades, downgrades and initiations from Wall Street early this Friday: Barrick Gold (ABX)…

Douglas A. McIntyre | Aug 12, 2009 at 9:26 AM EDT

Top Day Trader Alerts (JASO, GRMN, YRCW, JAZZ, MEDX, BMY, PETD, TOL, XHB, BRCM)

These are this morning’s top day trader alerts and most active in price and volume. We have more detailed analysis…

Douglas A. McIntyre | Aug 10, 2009 at 10:56 AM EDT

The War On Diabetes Heats Up (NVO, AMLN, LLY, MNKD, PFE, VVUS, BMY, AZN, ARNA, GERN, STEM, OREX, GNBT, SPEX, ORMP, HDIX, PODD)

Diabetes is becoming an epidemic in the U.S. and the Western World. The ties to obesity are often direct, so…

Douglas A. McIntyre | Jul 23, 2009 at 9:12 AM EDT

Bristol-Myers Gets Key Assets With A Medarex Deal (BMY, MEDX, ABT, JNJ, AMGN, WYE)

Bristol Myers Inc. (NYSE: BMY) plans to spend $2.4 billion to buy partner Medarex Inc. (Nasdaq: MEDX). It will get…

Douglas A. McIntyre | Jul 23, 2009 at 2:57 AM EDT

Media Digest 7/23/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

Reuters: Obama says healthcare reform is essential to the recovery. Reuters: CIT (CIT) bond advisers will push for Chapter 11.…

Douglas A. McIntyre | Jul 22, 2009 at 4:01 AM EDT

The Next Blockbuster Drugs: A $170 Billion Opportunity

Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line…

1 … 33 34 35 36 37 … 39

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Friday’s Top Options Alert: Bristol-Myers & Mead Johnson (BMY, MJN)

The Unusual Suspects (ADBE, BBY, NKE, ORCL, RIMM, AMZN, AXA, BMY, MJN, OSIP, UUP, V, WFC)

FDA: Thin Blood, Sour Stomach (AZN)(BMY)(SNY)

Bristol-Myers Cleans Up on Mead Johnson (BMY, MJN)

Media Digest 11/16/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

The 100 Hardest Working Brands In The World

Top Analyst Upgrades (AMD, AMGN, BDK, BMY, CTXS, KR, MA, PCG, SYMC, V, VMW)

Top Analyst Upgrades (AKS, BMY, CREE, JPM, LRCX, MAR, RIMM, SVNT, SE, VIA)

Media Digest 8/31/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

Top Analyst Upgrades and Downgrades (ABX, BDX, BMY, FUN, JCG, NEM, NENG, SNY, ZOLT)

Top Day Trader Alerts (JASO, GRMN, YRCW, JAZZ, MEDX, BMY, PETD, TOL, XHB, BRCM)

The War On Diabetes Heats Up (NVO, AMLN, LLY, MNKD, PFE, VVUS, BMY, AZN, ARNA, GERN, STEM, OREX, GNBT, SPEX, ORMP, HDIX, PODD)

Bristol-Myers Gets Key Assets With A Medarex Deal (BMY, MEDX, ABT, JNJ, AMGN, WYE)

Media Digest 7/23/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

The Next Blockbuster Drugs: A $170 Billion Opportunity

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Amazon and Tesla Drive One-Third of FDIS as U.S. Spending Surges Despite Recession-Level Sentiment

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Friday’s Top Options Alert: Bristol-Myers & Mead Johnson (BMY, MJN)

The Unusual Suspects (ADBE, BBY, NKE, ORCL, RIMM, AMZN, AXA, BMY, MJN, OSIP, UUP, V, WFC)

FDA: Thin Blood, Sour Stomach (AZN)(BMY)(SNY)

Bristol-Myers Cleans Up on Mead Johnson (BMY, MJN)

Media Digest 11/16/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

The 100 Hardest Working Brands In The World

Top Analyst Upgrades (AMD, AMGN, BDK, BMY, CTXS, KR, MA, PCG, SYMC, V, VMW)

Top Analyst Upgrades (AKS, BMY, CREE, JPM, LRCX, MAR, RIMM, SVNT, SE, VIA)

Media Digest 8/31/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

Top Analyst Upgrades and Downgrades (ABX, BDX, BMY, FUN, JCG, NEM, NENG, SNY, ZOLT)

Top Day Trader Alerts (JASO, GRMN, YRCW, JAZZ, MEDX, BMY, PETD, TOL, XHB, BRCM)

The War On Diabetes Heats Up (NVO, AMLN, LLY, MNKD, PFE, VVUS, BMY, AZN, ARNA, GERN, STEM, OREX, GNBT, SPEX, ORMP, HDIX, PODD)

Bristol-Myers Gets Key Assets With A Medarex Deal (BMY, MEDX, ABT, JNJ, AMGN, WYE)

Media Digest 7/23/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

The Next Blockbuster Drugs: A $170 Billion Opportunity

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Amazon and Tesla Drive One-Third of FDIS as U.S. Spending Surges Despite Recession-Level Sentiment

Featured Reads

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s